Dr. Sashidhar Reddy, MD
What this data tells you about Dr. Reddy
Dr. Sashidhar Reddy is a hematology & oncology in Allen, TX, with 19 years in practice. Based on federal Medicare data, Dr. Reddy performed 39,722 Medicare services across 2,789 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $4,553 from 49 pharmaceutical and/or device companies across 164 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 18,000 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 11,100 | $0 | $5 |
| Dexamethasone injection (steroid) | 1,665 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 1,560 | $18 | $67 |
| Anti-nausea injection (Aloxi/palonosetron) | 950 | $1 | $114 |
| Blood draw (venipuncture) | 900 | $8 | $20 |
| Complete blood count (CBC) with differential | 882 | $8 | $36 |
| Office visit, established patient (30-39 min) | 678 | $92 | $368 |
| Comprehensive metabolic blood panel | 606 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 540 | $0 | $24 |
| Administration of chemotherapy into vein, 1 hour or less | 223 | $98 | $707 |
| Injection of additional new drug or substance into vein | 210 | $12 | $108 |
| Injection, zoledronic acid, 1 mg | 186 | $7 | $431 |
| Iron level test | 170 | $6 | $27 |
| Iron binding capacity test | 170 | $9 | $35 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 169 | $48 | $313 |
| Ferritin level test (iron stores) | 168 | $13 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 149 | $22 | $157 |
| Office visit, established patient (20-29 min) | 133 | $67 | $250 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 125 | $55 | $211 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 100 | $90 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 99 | $1,108 | $4,802 |
| Administration of chemotherapy into vein, each additional hour | 87 | $21 | $161 |
| Drug injection, under skin or into muscle | 85 | $10 | $96 |
| Lactate dehydrogenase (enzyme) level | 84 | $6 | $31 |
| Microscopic examination for white blood cells with manual cell count | 83 | $4 | $22 |
| Complete blood count (CBC), automated | 83 | $6 | $34 |
| Administration of additional new drug or substance into vein, 1 hour or less | 71 | $49 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 67 | $1 | $7 |
| New patient office visit (45-59 min) | 65 | $119 | $565 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 52 | $26 | $145 |
| Unclassified drugs | 47 | $1 | $8 |
| Irrigation of implanted venous access drug delivery device | 43 | $18 | $114 |
| Red blood count, automated test | 38 | $4 | $23 |
| Infusion, normal saline solution , 1000 cc | 36 | $2 | $19 |
| Infusion into a vein for hydration, each additional hour | 28 | $10 | $75 |
| Nuclear medicine study whole body with ct scan | 21 | $1,109 | $4,929 |
| Manual urinalysis test with examination using microscope, non-automated | 18 | $4 | $26 |
| Injection of drug or substance into vein | 18 | $28 | $247 |
| New patient office visit, complex (60-74 min) | 13 | $149 | $709 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 24% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with iron sucrose injection (venofer)?
Does Dr. Reddy receive payments from pharmaceutical companies?
How do Dr. Reddy's costs compare to other hematology & oncologys in Allen?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology